News Highlights: Top Company News of the Day
IBM's Earnings Are Coming. Watch for More Details on Its Spinoff.
When the tech company reports earnings on Monday, investors are
likely to focus on any new details about IBM's planned spinoff of
its managed information services business.
GM to Help Build $2.3 Billion Battery Plant in Tennessee
Factory will be the second for the auto maker's joint venture
with LG Chem, one of the largest makers of batteries for electric
Morgan Stanley Books Archegos Loss, but Profit Hits a High
The bank lost $911 million when Archegos Capital Management
imploded last month, tarnishing a record-setting quarter.
Indianapolis Mass Shooting: At Least Eight Dead at FedEx Facility
The gunman arrived at the parking lot, got out of his car and
started shooting. After killing people outside and inside the
facility, he apparently killed himself.
Apple Music Reveals How Much It Pays When You Stream a Song
The company pays the music industry a penny per stream on its
service, a disclosure it made as part of an effort by
music-streaming services to show they are artist-friendly.
Hertz Bankruptcy Bidding War Heats Up With New Counteroffer
Knighthead Capital Management and Certares Management, which
previously offered to buy Hertz out of bankruptcy but were eclipsed
by a competing group, returned with a sweetened bid.
Simon & Schuster Won't Distribute Policeman's Book About Breonna Taylor Shooting
The book's author, Jonathan Mattingly, was one of the three
Louisville police officers who fired their weapons during last
ESG Insights - Johnson & Johnson Under the Microscope
This week, The Wall Street Journal's ESG research analysts
looked at J&J's vaccine pause, Microsoft's acquisition of
Nuance, the Veolia-Suez deal, Air Canada and more.
Toshiba Shareholders May Finally Get Their Due
Storied Japanese company Toshiba has a long history of
governance problems, but the prospect of a bidding war means things
could finally be looking up.
J&J Privately Asked Rival Vaccine Makers to Probe Clot Risks
AstraZeneca was interested in joining forces to investigate the
safety issue and communicate vaccine benefits and risks, but Pfizer
and Moderna didn't see the need for group action.
(END) Dow Jones Newswires
April 16, 2021 15:00 ET (19:00 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.